Clinical Diagnosis-Ophthalmology Pearls for better diagnosis, treatment of red eye February 15, 2017 By Vanessa Caceres Ophthalmologists should consider various potential problems, including a number of systemic conditions and infections, when examining a rare or persistent red eye. Why Acanthamoeba diagnosis is often challenging February 01, 2017 Having an awareness of current best practices—such as epidemiology, risk factors, signs and symptoms, and tests—can be key to identifying and treating corneal infections. Tracking treatment adherence in newly diagnosed open-angle glaucoma January 01, 2017 By Lynda Charters An analysis of U.S. claims data reveals a substantial proportion of patients (17%) remained untreated 4 years after their initial diagnosis of open-angle glaucoma. Poor oral health may be associated with POAG January 01, 2017 By Nancy Groves Recent tooth loss and periodontal disease have been linked to primary open-angle glaucoma in a large prospective study of male health professionals. Add-on module enhances diagnostic accuracy in glaucoma January 01, 2017 By Nancy Groves A new add-on glaucoma module has the capability of creating an anatomic map of each patient’s eye by using two fixed landmarks. The module also includes an extensive reference data base. Hypochlorous acid eyelid wash reduces bacterial load November 01, 2016 By Fred Gebhart Researchers studied the magnitude of bacterial load reduction on the surface of the skin 20 minutes after application of saline containing 0.01% pure hypochlorous acid as the preservative to the skin below the lower eyelid. Simultaneous ocular myasthenia gravis and thyroid eye disease: beware Thyroid eye disease (TED) is an autoimmune disease that is usually seen in patients with Graves’ thyrotoxicosis although it can also be seen in hypothyroid as well as euthyroid patients. Myasthenia gravis (MG) is also an autoimmune antibody mediated disorder characterized by fluctuating weakness of the skeletal muscles that can occur with TED. Managing ocular surface disease in patients with glaucoma October 01, 2016 By Inder Paul Singh MD Treating ocular surface disease may have an impact on the effectiveness of glaucoma treatment. Inder Paul Singh, MD, offers some strategies used in practice. Study: Not all topography devices are alike October 01, 2016 By Vanessa Caceres Subclinical haze after CXL can affect corneal topography measurements; a comparison shows that measurements with four different devices cannot be used interchangeably. Similarities seen in ocular protein deposits in glaucoma, dementia October 01, 2016 By Fred Gebhart The latest findings in the similarities between protein deposits seen in the eyes of patients with glaucoma and those with dementia are highlighted.